1. Home
  2. MDCX vs NTIP Comparison

MDCX vs NTIP Comparison

Compare MDCX & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDCX
  • NTIP
  • Stock Information
  • Founded
  • MDCX 2008
  • NTIP 1990
  • Country
  • MDCX Canada
  • NTIP United States
  • Employees
  • MDCX N/A
  • NTIP N/A
  • Industry
  • MDCX
  • NTIP Multi-Sector Companies
  • Sector
  • MDCX
  • NTIP Miscellaneous
  • Exchange
  • MDCX Nasdaq
  • NTIP Nasdaq
  • Market Cap
  • MDCX 33.8M
  • NTIP 32.9M
  • IPO Year
  • MDCX N/A
  • NTIP 1998
  • Fundamental
  • Price
  • MDCX $3.68
  • NTIP $1.39
  • Analyst Decision
  • MDCX Strong Buy
  • NTIP
  • Analyst Count
  • MDCX 1
  • NTIP 0
  • Target Price
  • MDCX $10.00
  • NTIP N/A
  • AVG Volume (30 Days)
  • MDCX 19.1K
  • NTIP 11.7K
  • Earning Date
  • MDCX 01-01-0001
  • NTIP 03-07-2025
  • Dividend Yield
  • MDCX N/A
  • NTIP 7.22%
  • EPS Growth
  • MDCX N/A
  • NTIP N/A
  • EPS
  • MDCX N/A
  • NTIP N/A
  • Revenue
  • MDCX N/A
  • NTIP $1,881,000.00
  • Revenue This Year
  • MDCX N/A
  • NTIP N/A
  • Revenue Next Year
  • MDCX N/A
  • NTIP N/A
  • P/E Ratio
  • MDCX N/A
  • NTIP N/A
  • Revenue Growth
  • MDCX N/A
  • NTIP 129.39
  • 52 Week Low
  • MDCX $1.80
  • NTIP $1.22
  • 52 Week High
  • MDCX $3.87
  • NTIP $2.25
  • Technical
  • Relative Strength Index (RSI)
  • MDCX N/A
  • NTIP 53.56
  • Support Level
  • MDCX N/A
  • NTIP $1.36
  • Resistance Level
  • MDCX N/A
  • NTIP $1.41
  • Average True Range (ATR)
  • MDCX 0.00
  • NTIP 0.02
  • MACD
  • MDCX 0.00
  • NTIP 0.00
  • Stochastic Oscillator
  • MDCX 0.00
  • NTIP 70.00

About MDCX Medicus Pharma Ltd. Common Stock

Medicus Pharma Ltd is a clinical-stage, multi-strategy holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA approved clinical trials.

About NTIP Network-1 Technologies Inc.

Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property rights. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.

Share on Social Networks: